vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是PDF SOLUTIONS INC的1.2倍（$75.5M vs $62.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 24.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $7.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.9%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
PBYI vs PDFS — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$62.4M
营收增速更快
PBYI
高出3.1%
24.6%
自由现金流更多
PBYI
多$6.8M
$7.5M
两年增速更快
PBYI
近两年复合增速
22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $62.4M |
| 净利润 | — | $-48.0K |
| 毛利率 | 69.3% | 72.9% |
| 营业利润率 | 22.7% | 5.5% |
| 净利率 | — | -0.1% |
| 营收同比 | 27.7% | 24.6% |
| 净利润同比 | — | -108.9% |
| 每股收益（稀释后） | $0.26 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPDFS
| Q4 25 | $75.5M | $62.4M | ||
| Q3 25 | $54.5M | $57.1M | ||
| Q2 25 | $52.4M | $51.7M | ||
| Q1 25 | $46.0M | $47.8M | ||
| Q4 24 | $59.1M | $50.1M | ||
| Q3 24 | $80.5M | $46.4M | ||
| Q2 24 | $47.1M | $41.7M | ||
| Q1 24 | $43.8M | $41.3M |
净利润PBYIPDFS
| Q4 25 | — | $-48.0K | ||
| Q3 25 | $8.8M | $1.3M | ||
| Q2 25 | $5.9M | $1.1M | ||
| Q1 25 | $3.0M | $-3.0M | ||
| Q4 24 | — | $539.0K | ||
| Q3 24 | $20.3M | $2.2M | ||
| Q2 24 | $-4.5M | $1.7M | ||
| Q1 24 | $-4.8M | $-393.0K |
毛利率PBYIPDFS
| Q4 25 | 69.3% | 72.9% | ||
| Q3 25 | 77.7% | 72.3% | ||
| Q2 25 | 76.5% | 71.2% | ||
| Q1 25 | 77.1% | 72.9% | ||
| Q4 24 | 76.4% | 68.3% | ||
| Q3 24 | 63.9% | 73.1% | ||
| Q2 24 | 77.4% | 70.6% | ||
| Q1 24 | 75.5% | 67.3% |
营业利润率PBYIPDFS
| Q4 25 | 22.7% | 5.5% | ||
| Q3 25 | 17.6% | 8.5% | ||
| Q2 25 | 12.7% | 2.2% | ||
| Q1 25 | 8.7% | -7.4% | ||
| Q4 24 | 22.6% | 1.0% | ||
| Q3 24 | 27.4% | 4.6% | ||
| Q2 24 | -4.6% | 0.6% | ||
| Q1 24 | -5.3% | -4.7% |
净利率PBYIPDFS
| Q4 25 | — | -0.1% | ||
| Q3 25 | 16.2% | 2.3% | ||
| Q2 25 | 11.2% | 2.2% | ||
| Q1 25 | 6.5% | -6.3% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | 25.2% | 4.8% | ||
| Q2 24 | -9.6% | 4.1% | ||
| Q1 24 | -11.0% | -1.0% |
每股收益（稀释后）PBYIPDFS
| Q4 25 | $0.26 | $0.00 | ||
| Q3 25 | $0.17 | $0.03 | ||
| Q2 25 | $0.12 | $0.03 | ||
| Q1 25 | $0.06 | $-0.08 | ||
| Q4 24 | $0.40 | $0.01 | ||
| Q3 24 | $0.41 | $0.06 | ||
| Q2 24 | $-0.09 | $0.04 | ||
| Q1 24 | $-0.10 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $42.2M |
| 总债务越低越好 | $22.7M | $67.0M |
| 股东权益账面价值 | $130.3M | $271.0M |
| 总资产 | $216.3M | $418.7M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPDFS
| Q4 25 | $97.5M | $42.2M | ||
| Q3 25 | $94.4M | $35.9M | ||
| Q2 25 | $96.0M | $40.4M | ||
| Q1 25 | $93.2M | $54.1M | ||
| Q4 24 | $101.0M | $114.9M | ||
| Q3 24 | $96.7M | $120.2M | ||
| Q2 24 | $96.8M | $117.9M | ||
| Q1 24 | $107.2M | $122.9M |
总债务PBYIPDFS
| Q4 25 | $22.7M | $67.0M | ||
| Q3 25 | $34.0M | $67.6M | ||
| Q2 25 | $45.3M | $68.1M | ||
| Q1 25 | $56.7M | $68.7M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPDFS
| Q4 25 | $130.3M | $271.0M | ||
| Q3 25 | $115.3M | $264.4M | ||
| Q2 25 | $104.7M | $257.5M | ||
| Q1 25 | $97.1M | $249.0M | ||
| Q4 24 | $92.1M | $246.0M | ||
| Q3 24 | $71.1M | $240.5M | ||
| Q2 24 | $48.5M | $232.2M | ||
| Q1 24 | $51.0M | $225.4M |
总资产PBYIPDFS
| Q4 25 | $216.3M | $418.7M | ||
| Q3 25 | $202.9M | $406.4M | ||
| Q2 25 | $194.9M | $391.1M | ||
| Q1 25 | $196.2M | $390.0M | ||
| Q4 24 | $213.3M | $315.3M | ||
| Q3 24 | $220.7M | $307.4M | ||
| Q2 24 | $205.0M | $298.0M | ||
| Q1 24 | $214.1M | $286.8M |
负债/权益比PBYIPDFS
| Q4 25 | 0.17× | 0.25× | ||
| Q3 25 | 0.30× | 0.26× | ||
| Q2 25 | 0.43× | 0.26× | ||
| Q1 25 | 0.58× | 0.28× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $7.5M |
| 自由现金流率自由现金流/营收 | 19.1% | 12.1% |
| 资本支出强度资本支出/营收 | 0.0% | 15.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-8.6M |
8季度趋势，按日历期对齐
经营现金流PBYIPDFS
| Q4 25 | $14.4M | $17.3M | ||
| Q3 25 | $9.7M | $3.3M | ||
| Q2 25 | $14.1M | $-5.2M | ||
| Q1 25 | $3.6M | $8.6M | ||
| Q4 24 | $15.6M | $1.6M | ||
| Q3 24 | $11.0M | $9.3M | ||
| Q2 24 | $1.0M | $684.0K | ||
| Q1 24 | $11.2M | $-1.9M |
自由现金流PBYIPDFS
| Q4 25 | $14.4M | $7.5M | ||
| Q3 25 | $9.7M | $-2.9M | ||
| Q2 25 | $14.1M | $-13.8M | ||
| Q1 25 | $3.6M | $535.0K | ||
| Q4 24 | $15.6M | $-4.0M | ||
| Q3 24 | $11.0M | $5.1M | ||
| Q2 24 | $1.0M | $-4.6M | ||
| Q1 24 | — | $-3.9M |
自由现金流率PBYIPDFS
| Q4 25 | 19.1% | 12.1% | ||
| Q3 25 | 17.7% | -5.1% | ||
| Q2 25 | 26.8% | -26.6% | ||
| Q1 25 | 7.7% | 1.1% | ||
| Q4 24 | 26.4% | -8.0% | ||
| Q3 24 | 13.7% | 11.0% | ||
| Q2 24 | 2.1% | -11.1% | ||
| Q1 24 | — | -9.4% |
资本支出强度PBYIPDFS
| Q4 25 | 0.0% | 15.7% | ||
| Q3 25 | 0.0% | 10.8% | ||
| Q2 25 | 0.0% | 16.5% | ||
| Q1 25 | 0.1% | 17.0% | ||
| Q4 24 | 0.0% | 11.3% | ||
| Q3 24 | 0.0% | 9.0% | ||
| Q2 24 | 0.0% | 12.8% | ||
| Q1 24 | 0.0% | 4.9% |
现金转化率PBYIPDFS
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 2.54× | ||
| Q2 25 | 2.41× | -4.55× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | 0.54× | 4.20× | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
